Interruption of Ganglioside Synthesis Produces Central Nervous System Degeneration and Altered Axon-Glial Interactions
Gangliosides, which are sialylated glycosphingolipids, are the major class of glycoconjugates on neurons and carry the majority of the sialic acid within the central nervous system (CNS). To determine the role of ganglioside synthesis within the CNS, mice carrying null mutations in two critical gang...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 8; pp. 2725 - 2730 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
22-02-2005
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Gangliosides, which are sialylated glycosphingolipids, are the major class of glycoconjugates on neurons and carry the majority of the sialic acid within the central nervous system (CNS). To determine the role of ganglioside synthesis within the CNS, mice carrying null mutations in two critical ganglioside-specific glycosyltransferase genes, Siat9 (encoding GM3 synthase) and Galgt1 (encoding GM2 synthase), were generated. These double-null mice were unable to synthesize gangliosides of the ganglio-series of glycosphingolipids, which are the major ganglioside class in the CNS. Soon after weaning, viable mice developed a severe neuro-degenerative disease that resulted in death. Histopathological examination revealed striking vacuolar pathology in the white matter regions of the CNS with axonal degeneration and perturbed axon-glia interactions. These results indicate that ganglioside synthesis is essential for the development of a stable CNS, possibly by means of the promotion of interactions between axon and glia. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 This paper was submitted directly (Track II) to the PNAS office. T.Y., Y.-P.W., and R.S. contributed equally to this work. To whom correspondence may be sent at the present address: Department of Cell Processing, Institute of Medical Science, Shirokanedai 4-6-1, Minato-ku Tokyo, 108-8639 Japan. E-mail: ty10104@ims.u-tokyo.ac.jp. ††To whom correspondence may be addressed. E-mail: proia@nih.gov. Edited by Roscoe O. Brady, National Institutes of Health, Bethesda, MD, and approved January 14, 2005 Abbreviations: GFAP, glial fibrillary acidic protein; MAG, myelin-associated glycoprotein. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0407785102 |